Shares in Chinese pharma firm tank as COVID-19 medicine Lianhua Qingwen questioned ChinaPulse.com China News, Data, Media Intelligence and Insights


Source: chinapulse.com chinapulse.com

Key Topics in this News Article:

News Snapshot:

News Snapshot: Shares in one of China's largest traditional medicine producers plunged on Monday (Apr 18) after reports questioned the efficacy of pills approved by the government as a coronavirus treatment. Shanghai authorities have joined their Hong Kong counterparts in handing out "Lianhua Qingwen" - a herbal remedy marketed for fever and sore throats - as the cities battle their worst COVID-19 outbreaks since the pandemic's start. But on Sunday, popular Chinese health platform Dingxiang Yisheng said the capsules, made by Shijiazhuang Yiling Pharmaceutical, could not prevent cases of the virus, in a report then picked up by state media....